Logo

Scienion Raises $5.7M in Financing

Jul 18, 2006

NEW YORK, July 18 (GenomeWeb News) - Scienion raised more than €4.5 million ($5.7 million) in its latest round of financing, the company said today.

 

The company expects to use the funds to establish a second development and production site in Dortmund, Germany, and will move into new facilities in the BioMedizinZentrum Dortmund. Scienion will also develop low-level liquid-handling technologies and applications as part of its expansion strategy.

 

New investors Nrw.Bank and S-Venture Capital Dortmund joined current investors Peppermint Financial Partners, VC Fonds Berlin of IBB and ERP Start Fonds of Kreditanstalt für Wiederaufbau in this round.

 

Scienion raised €6 million in its first round of financing in 2001.

Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.